Related Experiment Video
Updated: Jun 4, 2026
10:37
Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice
Published on: January 16, 2015
COPD pathology in the small airways.
G Caramori1, P Casolari, S Giuffrè
1Asthma and COPD Research Center, University of Ferrara, Ferrara, Italy. gaetano.caramori@unife.it
Panminerva Medica
|February 25, 2011
Summary
Analysis of small airways in chronic obstructive pulmonary disease (COPD) reveals key cellular and molecular players in disease pathogenesis. This knowledge aids in developing targeted therapies for stable COPD patients.
Area of Science:
- Pulmonary Medicine
- Pathology
- Immunology
Background:
- Chronic Obstructive Pulmonary Disease (COPD) significantly impacts lung health, particularly affecting small airways.
- Understanding the cellular and molecular mechanisms in small airway pathology is crucial for effective COPD management.
- Previous research has highlighted the role of inflammation and structural changes in COPD pathogenesis.
Purpose of the Study:
- To review and discuss the pathology of small airways in stable COPD patients across different severity levels.
- To compare small airway findings in COPD patients with those of age-matched healthy smokers.
- To consolidate current knowledge on cellular, mediator, and signaling pathway involvement in COPD pathogenesis.
Main Methods:
- Analysis of small airways specimens from COPD patients and control smokers.
- Comparative study focusing on inflammatory and structural cells.
- Examination of pro/anti-inflammatory mediators and intracellular signaling pathways.
Main Results:
- Novel insights into the roles of various inflammatory and structural cells in stable COPD.
- Identification of key pro/anti-inflammatory mediators contributing to disease pathogenesis.
- Understanding of intracellular signaling pathways involved in small airway remodeling.
Conclusions:
- The study of small airways provides a deeper understanding of stable COPD pathogenesis.
- Findings offer a scientific rationale for the discovery and development of new small airway-targeted drugs.
- This review synthesizes current knowledge, guiding future therapeutic strategies for COPD.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.